LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
About LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Lixte Biotechnology Holdings Inc is a clinical-stage biopharmaceutical and proton cancer therapy company focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The company's drug product pipeline is focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. Its product is LB-100 for Ovarian Clear Cell Carcinoma and Metastatic Colon Cancer. The company operates in a single reportable segment, which consists of the development of cancer treatments.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2015
- $200.0K
- Net income
- -$6.1M
- Total assets
- $12.7M
- Market cap
- $121.7M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $5.1M
- Operating income
- -$5.1M
- Net income
- -$6.0M
- EPS (diluted)
- $-1.26
Balance sheet
- Total assets
- $12.7M
- Current assets
- $5.2M
- Total liabilities
- $1.8M
- Current liabilities
- $1.3M
- Shareholders’ equity
- $11.0M
Cash flow
- Operating cash flow
- -$3.1M
- Net cash flow
- -$3.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $121.7M
- EPS (diluted)
- $-1.26
- Shares outstanding
- 16.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 5, 2007
Lixte Biotechnology Holdings, Inc. (LIXT) Stock Price
- Reported a net loss of $6.1M in FY2015.
- Trading 10% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LIXTE BIOTECHNOLOGY HOLDINGS, INC..
Write a review
News about LIXTE BIOTECHNOLOGY HOLDINGS, INC.
News & sentiment via Polygon.io
Lixte Biotechnology Holdings, Inc.: frequently asked questions
Is Lixte Biotechnology Holdings, Inc. an American company?
Lixte Biotechnology Holdings, Inc. is a US-based company headquartered in Boca Raton, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Lixte Biotechnology Holdings, Inc. headquartered?
Lixte Biotechnology Holdings, Inc. is headquartered in Boca Raton, Florida, United States.
Is Lixte Biotechnology Holdings, Inc. publicly traded?
Yes — Lixte Biotechnology Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol LIXT on the NASDAQ.
What does Lixte Biotechnology Holdings, Inc. do?
Lixte Biotechnology Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
